Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 62 results for rheumatology

  1. Rheumatoid arthritis in over 16s (QS33)

    This quality standard covers assessing, diagnosing and managing rheumatoid arthritis in over 16s. It describes high-quality care in priority areas for improvement.

  2. Rheumatology referral prioritisation: the right care in the right place at the right time

    Organisation: Princess of Wales Hospital and British Society for Rheumatology Published date: January 2017

  3. Spondyloarthritis (QS170)

    This quality standard covers diagnosing and managing spondyloarthritis in adults aged 16 and over. It describes high-quality care in priority areas for improvement.

  4. Spondyloarthritis in over 16s: diagnosis and management (NG65)

    This guideline covers diagnosing and managing spondyloarthritis that is suspected or confirmed in adults who are 16 years or older. It aims to raise awareness of the features of spondyloarthritis and provide clear advice on what action to take when people with signs and symptoms first present in healthcare settings. It also provides advice on the range of treatments available.

  5. Diagnosis and referral of inflammatory arthritis

    of Musculoskeletal Health , 2021. Diagnoses of people referred into rheumatology with suspected inflammatory arthritis // Early...

  6. Gout: diagnosis and management (NG219)

    This guideline covers the diagnosis and management of gout. It includes recommendations on diagnosing gout, managing flares, long-term management of gout and referral to specialist services.

  7. Management of inflammatory arthritis

    approach is called 'treat-to-target'. Data from the British Society of Rheumatology's National Early Inflammatory Arthritis (NEIA) Audit...

  8. Developing an Annual Review Clinic for People with Rheumatoid Arthritis

    Arthritis. The Annual Review is a 40 minute appointment carried out by a Rheumatology Nurse Specialist and is a holistic review of the...

  9. Manchester Royal Infirmary Virtual Biologics Clinic

    database Organisation: British Society for Rheumatology and Manchester Royal Infirmary Published date:

  10. Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis (TA308)

    Evidence-based recommendations on rituximab (MabThera) with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in adults.

  11. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (TA195)

    Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade), rituximab (MabThera) and abatacept (Orencia). These drugs are for adults with severe rheumatoid arthritis who have tried other disease-modifying antirheumatic drugs (DMARDs) but cannot tolerate them or they haven’t worked well enough.

  12. Integrating service, audit and research data to improve patient care

    Newcastle Upon Tyne NHS Foundation Trust & British Society for Rheumatology Published date: May 2017

  13. Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis (ES29)

    Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis

  14. Committee D members

    Find out more about NICE technology appraisals advisory committee D members

  15. Tocilizumab for treating giant cell arteritis (TA518)

    Evidence-based recommendations on tocilizumab (RoActemra) for treating giant cell arteritis in adults.